![Thomas McCauley](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Thomas McCauley
Hoofd Techniek/Wetenschap/O&O bij
STOKE THERAPEUTICS, INC.
Profiel
Thomas McCauley is currently Chief Scientific Officer at Stoke Therapeutics, Inc. since 2026.
Formerly, Dr. McCauley was President & Chief Executive Officer at Neptune Biotech, Inc. Chief Scientific Officer at Translate Bio, Inc. from 2016 to 2018.
Chief Scientific Officer at Zikani Therapeutics, Inc. from 2018 to 2019.
Vice President at Shire Pharmaceuticals, Inc. from 2010 to 2016.
Chief Scientific Officer at Omega Therapeutics, Inc. from 2019 to 2024.
Education includes undergraduate studies at Cornell University and a doctorate from The University of Alabama at Birmingham.
Actieve functies van Thomas McCauley
| Bedrijven | Functie | Begin |
|---|---|---|
| STOKE THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 13-07-2026 |
Eerdere bekende functies van Thomas McCauley
| Bedrijven | Functie | Einde |
|---|---|---|
| OMEA THER | Hoofd Techniek/Wetenschap/O&O | 14-08-2024 |
Zikani Therapeutics, Inc.
 Zikani Therapeutics, Inc. Drugstore ChainsRetail Trade Focuses on the discovery and development of novel macrolide antibiotics for the treatment of life-threatening bacterial infections caused by drug resistant pathogens | Corporate Officer/Principal | 01-07-2019 |
| TRANSLATE BIO, INC. | Corporate Officer/Principal | 01-04-2018 |
Shire Pharmaceuticals, Inc.
 Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 01-08-2016 |
Opleiding van Thomas McCauley
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
70
Eerstegraads connecties
7
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 7 |
|---|---|
Translate Bio, Inc.
 Translate Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage mRNA therapeutics company that develops transformative medicines to treat diseases caused by protein | Health Technology |
Zikani Therapeutics, Inc.
Zikani Therapeutics, Inc. Drugstore ChainsRetail Trade Focuses on the discovery and development of novel macrolide antibiotics for the treatment of life-threatening bacterial infections caused by drug resistant pathogens | Retail Trade |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shire Pharmaceuticals, Inc.
Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
The University of Alabama at Birmingham
 The University of Alabama at Birmingham Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stoke Therapeutics, Inc.
 Stoke Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company focused on the development of first-in-class therapeutics that selectively increase gene expression to treat genetic diseases | Health Technology |
Omega Therapeutics, Inc.
 Omega Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for general and rare genetic diseases, immunology, inflammation, oncology and metabolic diseases | Health Technology |
